| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 DECEMBER 2024 |
| FOR |
| DOCTOR Q LIMITED |
| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 DECEMBER 2024 |
| FOR |
| DOCTOR Q LIMITED |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| DOCTOR Q LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Clyde Offices, 2nd Floor, |
| 48 West George Street |
| Glasgow |
| G2 1BP |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| BALANCE SHEET |
| 30 DECEMBER 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
7 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| BALANCE SHEET - continued |
| 30 DECEMBER 2024 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| 1. | STATUTORY INFORMATION |
| Doctor Q Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Going concern |
| The directors have considered the going concern basis in preparing these financial statements. They have concluded that the going concern basis is appropriate because sufficient funds will be generated from future trading of the company, as well as continued support from the directors and group companies, for a period of at least twelve months from the date of the approval of these financial statements to enable the Company to meet its liabilities as they arise. |
| The financial statements do not include any adjustments that would result from the withdrawal of this support. |
| The company has claimed the covid bounce back loans in more than one group company. As a result, this has been shown as fully due in 1 year. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Plant and machinery | - |
| Computer equipment | - |
| Financial instruments |
| The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares. |
| Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings. |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Plant and | Computer |
| machinery | equipment | Totals |
| £ | £ | £ |
| COST |
| At 31 December 2023 |
| and 30 December 2024 |
| DEPRECIATION |
| At 31 December 2023 |
| Charge for year |
| At 30 December 2024 |
| NET BOOK VALUE |
| At 30 December 2024 |
| At 30 December 2023 |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Amounts owed by group undertakings |
| Amounts owed by associates |
| Prepayments |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Other loans |
| Trade creditors |
| Amounts owed to group undertakings |
| Amounts owed to participating interests | 1,500 | 1,500 |
| Tax |
| VAT | 5,513 | 12,246 |
| Other creditors |
| Accrued expenses |
| 7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Other loans - 1-2 years | 5,871 | 7,538 |
| Other loans - 2-5 years | 26,140 | 28,960 |
| 8. | RELATED PARTY DISCLOSURES |
| During the period the Company operated loan accounts with group companies which is included within debtors. The amount due from group companies at the period end was £472,855 ( 2023 - £628,608). These loans are unsecured, interest free and repayable on demand. |
| During the period the Company operated a loan account with companies under common control. The amount due from companies under common control was £303,437 (2023 - £303,437). This loan is unsecured, interest and repayable on demand. |
| During the period the Company owed interested parties by virtue of their 100% shareholding in Qureshi Group Limited £1,500 (2023 - £1,500) |
| DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 30 DECEMBER 2024 |
| 9. | ULTIMATE CONTROLLING PARTY |
| The ultimate controlling parent undertaking is Qureshi Group Limited by virtue of its 100% controlling interest in the company. |
| The Ultimate controlling parties are Dr U Qureshi and Mrs S Qureshi by virtue of their 100% shareholding in Qureshi Group Limited. |